Along these lines, most studies today are performed with the aim of CPP-mediated siRNA delivery in vivo. Although many of them are already showing promising results, e.g. concerning tumor-targeting and ocular delivery [96] [97] [98] , this is beyond the scope of this review and will be discussed elsewhere in this issue [99, 100] .